Skip Navigation
  Search Menu
Find an Expert

 

Nate Permpalung, M.D., M.P.H.

Nitipong Permpalung, M.D., M.P.H.

Photo of Dr. Nate Permpalung, M.D., M.P.H.

Male

Languages: English, Thai

Expertise: Infectious Disease, Transplant Infectious Diseases

Research Interests: Respiratory viral infections in transplant recipients; Invasive fungal infections; Human pythiosis

Locations

The Johns Hopkins Hospital

600 N. Wolfe Street Baltimore, MD 21287 map

Phone: 410-614-5509 | Fax: 410-955-0788

Johns Hopkins Rockland Physician Practice and Research Group

APPOINTMENT PHONE: 443-287-6217

10751 Falls Road Falls Concourse Suite 412 Lutherville, MD 21093 map

Phone: 410-583-2900 | Fax: 410-614-0714

Background

Dr. Nate Permpalung graduated from the Faculty of Medicine, Chulalongkorn University, Thailand in 2010. He completed a residency in Internal Medicine at Bassett Medical Center/Columbia University College of Physicians and Surgeons in 2015. He then completed a fellowship in Infectious Diseases at Beth Israel Deaconess Medical Center/Harvard Medical School in 2017. During his fellowship, he concurrently completed his Master of Public Health in Clinical Effectiveness from Harvard T.H. Chan School of Public Health in 2017 and he then completed a fellowship in Transplant Infectious Diseases at Duke University Medical Center in 2018.

After graduation, he joined the Transplant and Oncology Infectious Diseases Program at Johns Hopkins. His research interests include respiratory viral infections in lung transplant recipients, invasive fungal infections in transplant recipients, and human pythiosis.

...read more

Departments / Divisions

Education

Degrees

  • MD, Chulalongkorn University (2010)

Residencies

  • Bassett Medical Center / Internal Medicine (2015)

Fellowships

  • Beth Israel Deaconess Medical Center / Infectious Diseases (2017)
  • Duke University School of Medicine (2018)

Research & Publications

Selected Publications

Permpalung N, Worasilchai N, Manothummetha K, Torvorapanit P, Ratanawongphaibul K, Chuleerarux N, Plongla R, Chindamporn A. Clinical outcomes in ocular pythiosis patients treated with a combination therapy protocol in Thailand: A prospective study. Med Mycol. 2019 Feb 26. pii: myz013. doi: 10.1093/mmy/myz013. [Epub ahead of print] PMID:30805615.

Permpalung N, Mohoney MV, Alonso CD. Adjunctive use of cidofovir and intravenous immunoglobulin to treat invasive adenovirus disease in solid organ transplant recipients. Pharmacotherapy. 2018 Nov 7. PMID: 30403300

Permpalung N, Mahoney MV, McCoy C, Atsawarungruangkit A, Gold HS, Levine JD, Wong MT, LaSalvia MT, Alonso CD. Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy patients receiving palivizumab. Leuk Lymphoma. 2018 Jun 27:1-7. PMID:29947555

Worasilchai N, Permpalung N, Chongsathidkiet P, Leelahavanichkul A, Mendoza LA, Palaga T, Reantragoon R, Chindamporn A. Monitoring anti-Pythium IgG antibodies and (1,3)-ß-D-glucan in vascular pythiosis. J Clin Microbiol. 2018 May 30. PMID:29848566

Permpalung N, Sanguankeo A, Upala S, Sornprom S. Association between nonsteroidal anti- inflammatory drugs and Clostridium difficile-associated diarrhea: A systematic review and meta- analysis. Can J Gastroenterol Hepatol. 2015 Sep 11. PMID: 26359624

Activities & Honors

Honors

  • Highest Distinction (Academic Merit), Department of Medicine, Chulalongkorn University
  • Maxwell Finland Young Investigator Award, Massachusetts Infectious Diseases Society
  • Fred Hutchinson Cancer Research Center Travel Grant Award, Fred Hutchinson Cancer Research Center
  • IDWeek Trainee Travel Award, The Infectious Diseases Society of America

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile